Siddhesh Joshi

Andrew Kasarskis

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
Citizenship  American
Name  Andrew Kasarskis
Fields  Bioinformatics, Genomics

Andrew Kasarskis httpswwwmountsinaiorgstaticfilesfadimgne
Born  November 2, 1972 (age 43) Madison, Wisconsin (1972-11-02)
Institutions  Icahn School of Medicine at Mount Sinai Icahn Institute for Genomics and Multiscale Biology
Alma mater  University of Kentucky, University of California, Berkeley
Institution  Icahn School of Medicine at Mount Sinai, Icahn Institute for Genomics and Multiscale Biology

Andrew Kasarskis (born November 2, 1972, in Madison, Wisconsin) is an American biologist. He is director of the Icahn Institute for Genomics and Multiscale Biology and vice chair of the department of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai. Kasarskis is known for taking a network-based approach to biology and for directing the first medical school class offering students the opportunity to fully sequence and analyze their own genomes.

Contents

Andrew Kasarskis Mount Sinai Health System Andrew Kasarskis PhD

Education

Kasarskis completed bachelor's degrees in chemistry and biology at the University of Kentucky in 1992. In 1998, he completed his PhD in molecular and cell biology at the University of California, Berkeley, under the supervision of Kathryn Anderson.

Research

Throughout his career in industry and academia, Kasarskis’s research has focused on the use of genetic and genomic data together with high-performance computing and advanced analytical tools to address biomedical needs and improve clinical treatment.

After completing his PhD, Kasarskis worked at Stanford University for two years, contributing to the development of various genome databases. In 2000, he entered industry, working in computational biology at DoubleTwist and later Rosetta Inpharmatics (acquired by Merck Research Laboratories). His work there centered on generating and mining complex biological data sets and using that information to build, predict, and model human disease. Kasarskis also worked for Sage Bionetworks and Pacific Biosciences before returning to academia.

In 2011, Kasarskis became vice chair of the department of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai and co-director, along with Eric Schadt, of the Icahn Institute for Genomics and Multiscale Biology, where the goal is to use large-scale data analysis to improve patient treatment. His focus is on improving health outcomes through better data mining, and his research program includes sequencing-based pathogen surveillance; pharmacogenomics; electronic health records; and systems biology of sleep, behavior, and stress.

Kasarskis is known for directing the first class that allowed medical and PhD students to fully sequence and analyze their own genomes, along with co-instructors Michael Linderman, George Diaz, Ali Bashir, and Randi Zinberg. He has said that courses like this will be critical for training teams of people capable of performing this type of analysis in a medical setting. He chose whole genome sequencing because he expects the more limited exome sequencing will not be a relevant technological approach in the long term.

Kasarskis has called for improvements to informed consent protocols in patient research based on the concept that studies involving DNA cannot fully be made anonymous. He was quoted in the journal Nature saying, “We need to move beyond an assumption that you cannot be identified from the data that exist about you and really work to make sure that we’re protecting people’s rights in ways that allow us to use the data that are out there for individuals’ and researchers’ benefit.”

Pharmacogenomics

  • Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, Perl AE, Travers KJ, Wang S, Hunt JP, Zarrinkar PP, Schadt EE, Kasarskis A, Kuriyan J, Shah NP. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature. 2012 May 10;485(7397):260-3.
  • Kasarskis A, Yang X, Schadt E. Integrative genomics strategies to elucidate the complexity of drug response. Pharmacogenomics. 2011 Dec;12(12):1695-715.
  • Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, Lu F, Lyon E, Voelkerding KV, Zehnbauer BA, Agarwala R, Bennett SF, Chen B, Chin EL, Compton JG, Das S, Farkas DH, Ferber MJ, Funke BH, Furtado MR, Ganova-Raeva LM, Geigenmuller U, Gunselman SJ, Hegde MR, Johnson PL, Kasarskis A, Kulkarni S, Lenk T, Liu CS, Manion M, Manolio TA, Mardis ER, Merker JD, Rajeevan MS, Reese MG, Rehm HL, Simen BB, Yeakley JM, Zook JM, Lubin IM. Assuring the quality of next-generation sequencing in clinical laboratory practice" Nat Biotechnol 2012 Nov;30(11):1033-6.
  • Pathogens

  • Bashir A, Klammer AA, Robins WP, Chin CS, Webster D, Paxinos E, Hsu D, Ashby M, Wang S, Peluso P, Sebra R, Sorenson J, Bullard J, Yen J, Valdovino M, Mollova E, Luong K, Lin S, LaMay B, Joshi A, Rowe L, Frace M, Tarr CL, Turnsek M, Davis BM, Kasarskis A, Mekalanos JJ, Waldor MK, Schadt EE. A hybrid approach for the automated finishing of bacterial genomes" Nat Biotechnol 2012 Jul;30(7):701-7.
  • Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin CS, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Moller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med. 2011 Aug 25;365(8):709-17.
  • Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, Jean-Charles RR, Bullard J, Webster DR, Kasarskis A, Peluso P, Paxinos EE, Yamaichi Y, Calderwood SB, Mekalanos JJ, Schadt EE, Waldor MK. The origin of the Haitian cholera outbreak strain. N Engl J Med. 2011 Jan 6;364(1):33-42.
  • Sleep

  • Brunner, JI; Gotter, AL; Millstein, J; Garson, S; Binns, J; Fox, SV; Savitz, AT; Yang, HS; Fitzpatrick, K; Zhou, L; Owens, JR; Webber, AL; Vitaterna, MH; Kasarskis, A; Uebele, VN; Turek, F; Renger, JJ; Winrow, CJ (2011). "Pharmacological validation of candidate causal sleep genes identified in an N2 cross". Journal of Neurogenetics. 25: 167–81. PMC 3568991 . PMID 22091728. doi:10.3109/01677063.2011.628426. 
  • "Identification of causal genes, networks, and transcriptional regulators of REM sleep and wake". Sleep. Retrieved 2013-06-17. 
  • Winrow, CJ; Williams, DL; Kasarskis, A; Millstein, J; Laposky, AD; Yang, HS; Mrazek, K; Zhou, L; Owens, JR; Radzicki, D; Preuss, F; Schadt, EE; Shimomura, K; Vitaterna, MH; Zhang, C; Koblan, KS; Renger, JJ; Turek, FW. "Uncovering the Genetic Landscape for Multiple Sleep-Wake Traits". PLOS ONE. 4: e5161. PMC 2664962 . PMID 19360106. doi:10.1371/journal.pone.0005161. Retrieved 2013-06-10. 
  • References

    Andrew Kasarskis Wikipedia


    Similar Topics
    Frozen (2010 American film)
    Parvinder Awana
    Mike Slattery (politician)
    Topics